Literature DB >> 22469005

T-cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis--indication for an airborne antigen as the triggering factor in sarcoidosis.

P Darlington1, H Haugom-Olsen, K von Sivers, J Wahlström, M Runold, V Svjatoha, A Porwit, A Eklund, J Grunewald.   

Abstract

BACKGROUND: An increased percentage of CD4+ T cells is usually observed in bronchoalveolar lavage fluid (BALF) from patients with sarcoidosis. In HLA-DRB1*03-positive patients, such T cells express the T-cell receptor (TCR) AV2S3+ gene segment. It is not known whether cells found in BALF reflect those in enlarged regional lymph nodes (LNs). Therefore, the aim of this study was to compare T-cell phenotypes in BALF, blood and mediastinal LNs.
METHODS: Fifteen patients underwent clinical investigation including bronchoscopy with bronchoalveolar lavage. Blood samples were drawn, and endoscopic ultrasound-guided fine-needle aspiration of enlarged mediastinal LNs was performed via the oesophagus. T cells from all three compartments were analysed by flow cytometry for markers of activity, differentiation and T regulatory function.
RESULTS: The CD4/CD8 ratio was significantly higher in BALF compared with regional LNs and was also significantly higher in LNs than in blood. The CD4+ T cells were recently activated and more differentiated in BALF than in blood and LNs. There was an accumulation of T regulatory cells (FOXP3+) in LNs and a correlation between high levels of FOXP3+ cells in BALF and in LNs. In HLA-DRB1*03-positive patients, TCR AV2S3+ CD4+ T cells were predominantly localized within BALF.
CONCLUSIONS: The CD4+ T-cell phenotype in BALF indicates an active ongoing specific immune response primarily localized to the alveolar space.
© 2012 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22469005     DOI: 10.1111/j.1365-2796.2012.02543.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  11 in total

Review 1.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 2.  Etiologies of Sarcoidosis.

Authors:  Edward S Chen; David R Moller
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

3.  Therapeutic granulocyte and monocyte apheresis (GMA) for treatment refractory sarcoidosis: a pilot study of clinical effects and possible mechanisms of action.

Authors:  H H Olsen; V Muratov; K Cederlund; J Lundahl; A Eklund; J Grunewald
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 4.  Granuloma formation in pulmonary sarcoidosis.

Authors:  Caroline E Broos; Menno van Nimwegen; Henk C Hoogsteden; Rudi W Hendriks; Mirjam Kool; Bernt van den Blink
Journal:  Front Immunol       Date:  2013-12-10       Impact factor: 7.561

Review 5.  Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis.

Authors:  Pleiades T Inaoka; Masato Shono; Mishio Kamada; J Luis Espinoza
Journal:  J Biomed Sci       Date:  2019-06-11       Impact factor: 8.410

6.  Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis.

Authors:  S Kullberg; N V Rivera; M Abo Al Hayja; J Grunewald; A Eklund
Journal:  Clin Exp Immunol       Date:  2020-04-22       Impact factor: 4.330

7.  Subpopulations of cells from bronchoalveolar lavage can predict prognosis in sarcoidosis.

Authors:  Pernilla Darlington; Susanna Kullberg; Anders Eklund; Johan Grunewald
Journal:  Eur Respir J       Date:  2020-01-30       Impact factor: 16.671

8.  Mapping mononuclear phagocytes in blood, lungs, and lymph nodes of sarcoidosis patients.

Authors:  Rico Lepzien; Gregory Rankin; Jamshid Pourazar; Ala Muala; Anders Eklund; Johan Grunewald; Anders Blomberg; Anna Smed-Sörensen
Journal:  J Leukoc Biol       Date:  2019-02-11       Impact factor: 4.962

9.  Bronchoalveolar lavage fluid IFN-γ+ Th17 cells and regulatory T cells in pulmonary sarcoidosis.

Authors:  Anders Tøndell; Torolf Moen; Magne Børset; Øyvind Salvesen; Anne Dorthea Rø; Malcolm Sue-Chu
Journal:  Mediators Inflamm       Date:  2014-05-05       Impact factor: 4.711

10.  Flow cytometric analysis of lymphocyte profiles in mediastinal lymphadenopathy of sarcoidosis.

Authors:  Ken Akao; Tomoyuki Minezawa; Naoki Yamamoto; Takuya Okamura; Takahiro Inoue; Kumiko Yamatsuta; Sakurako Uozu; Yasuhiro Goto; Masamichi Hayashi; Sumito Isogai; Masashi Kondo; Kazuyoshi Imaizumi
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.